Delving into the Latest Updates on DVC-01 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Immune System DiseasesInfectious DiseasesCardiovascular Diseases+ [3]

Active Indication

Dermatitis, AtopicDermatitis, OccupationalDermatitis, Seborrheic+ [9]

Inactive Indication-

Originator Organization

Tianjin Pharm Research Inst Pharm Co Ltd.

Active Organization

Tianjin Pharmaceutical Research Institute Co Ltd.

Inactive Organization

Tianjin Pharm Research Inst Pharm Co Ltd.

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

Login to view timeline

主要目的：初步评价中国健康受试者经完整皮肤单次外用戊酸二氟可龙乳膏时，戊酸二氟可龙及二氟可龙的全身吸收情况和药代动力学特征。次要目的：初步评价中国健康受试者经完整皮肤单次外用戊酸二氟可龙乳膏时，用药局部和全身的安全性。

[Translation]

Primary objective: To preliminarily evaluate the systemic absorption and pharmacokinetic characteristics of diflucortolone valerate and diflucortolone when diflucortolone valerate cream is applied to Chinese healthy subjects via intact skin once. Secondary objective: To preliminarily evaluate the local and systemic safety of diflucortolone valerate cream when applied to Chinese healthy subjects once via intact skin once.

Start Date07 Jan 2020

Sponsor / Collaborator

Tianjin Pharmaceutical Research Institute Co Ltd.

CTR20190509 / RecruitingPhase 3

DVC-01治疗湿疹的有效性和安全性多中心、随机、双盲、赋形剂平行对照临床研究

[Translation] Efficacy and safety of DVC-01 in the treatment of eczema: a multicenter, randomized, double-blind, vehicle-controlled clinical study

评价DVC-01治疗湿疹的有效性和安全性。

[Translation]

To evaluate the efficacy and safety of DVC-01 in the treatment of eczema.

Start Date05 Nov 2018

Sponsor / Collaborator

Tianjin Pharmaceutical Research Institute Co Ltd.

100 Clinical Results associated with DVC-01

Login to view more data

100 Translational Medicine associated with DVC-01

Login to view more data

100 Patents (Medical) associated with DVC-01

Login to view more data

100 Deals associated with DVC-01

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Dermatitis, Occupational	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Dermatitis, Seborrheic	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Dermatophilosis	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Eczema, Dyshidrotic	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Lichen Planus	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Lupus Erythematosus, Discoid	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Neurodermatitis	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Psoriasis	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Sunburn	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Varicose Veins	Phase 3	CN	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018